National Oil and Hazardous Substances Pollution Contingency Plan; National Priorities List: Deletion of the Tomah Armory Landfill Superfund Site, 63146-63147 [2018-26492]
Download as PDF
63146
Federal Register / Vol. 83, No. 235 / Friday, December 7, 2018 / Proposed Rules
or an order declining the De Novo
request under 860.289(b).
(b) A requester may supplement or
amend a pending De Novo request to
revise existing information or provide
additional information.
(1) FDA may require additional
information regarding the device that is
necessary for FDA to complete the
review of the De Novo request.
(2) Additional information submitted
to FDA must include the reference
number assigned to the original De
Novo request and, if submitted on the
requester’s own initiative, the reason for
submitting the additional information.
(c) Prior to granting or declining a De
Novo request, FDA may inspect relevant
facilities to help determine:
(1) That clinical or nonclinical data
were collected in a manner that ensures
that the data accurately represents the
benefits and risks of the device; or
(2) That implementation of Quality
System Regulation (part 820 of this
chapter) requirements, in addition to
other general controls and any specified
special controls, provide adequate
assurance that critical and/or novel
manufacturing processes produce
devices that meet specifications
necessary to ensure reasonable
assurance of safety and effectiveness.
amozie on DSK3GDR082PROD with PROPOSALS1
§ 860.267
request.
Withdrawal of a De Novo
(a) FDA will consider a De Novo
request to have been withdrawn if:
(1) The requester fails to provide a
complete response to a request for
additional information pursuant to
§ 860.256(b)(1) within 180 days after the
date FDA issues such request;
(2) The requester fails to provide a
complete response to the deficiencies
identified by FDA pursuant to
§ 860.245(c)(2) within 180 days of the
date notification was issued by FDA;
(3) The requester does not permit an
authorized FDA employee an
opportunity to inspect the facilities,
pursuant to § 860.256(c), at a reasonable
time and in a reasonable manner, and to
have access to copy and verify all
records pertinent to the De Novo
request; or
(4) The requester submits a written
notice to FDA that the De Novo request
has been withdrawn.
(b) If FDA considers a De Novo
request to be withdrawn, the Agency
will notify the requester. The notice will
include the De Novo request reference
number and the date FDA considered
the De Novo request withdrawn.
§ 860.289
request.
Granting or declining a De Novo
(a)(1) FDA will issue to the requester
an order granting a De Novo request if
VerDate Sep<11>2014
16:06 Dec 06, 2018
Jkt 247001
none of the reasons in paragraph (b) of
this section for declining the De Novo
request applies.
(2) If FDA grants a De Novo request,
FDA will subsequently publish in the
Federal Register a notice of the
classification order, including any
special controls.
(b) FDA may issue written notice to
the requester declining a De Novo
request if the requester fails to follow
the requirements of this part or if, upon
the basis of the information submitted
in the De Novo request or any other
information before FDA, FDA
determines:
(1) The device does not meet the
criteria under section 513(a)(1) of the
Federal Food, Drug, and Cosmetic Act
and § 860.3 for classification into class
I or II;
(2) The De Novo request contains a
false statement of material fact or there
is a material omission;
(3) The device’s labeling does not
comply with the requirements in parts
801 and 809 of this chapter, as
applicable;
(4) The product described in the De
Novo request does not meet the
definition of a device under section
201(h) of the Federal Food, Drug, and
Cosmetic Act and is not a combination
product as defined at § 3.2(e) of this
chapter;
(5) The device is of a type which has
already been approved in existing
applications for premarket approval
(PMAs) submitted under part 814 of this
chapter;
(6) The device is of a type that has
already been classified into class I, class
II, or class III;
(7) An inspection of a relevant facility
under § 860.256(c) results in a
determination that general or general
and special controls would not provide
reasonable assurance of safety and
effectiveness;
(8) A nonclinical laboratory study that
is described in the De Novo request, and
that is essential to show there is
reasonable assurance of safety was not
conducted in compliance with the good
laboratory practice regulations in part
58 of this chapter and no reason for the
noncompliance is provided or, if a
reason is provided, the practices used in
conducting the study do not support the
validity of the study;
(9) A clinical investigation described
in the De Novo request involving human
subjects that is subject to the
institutional review board regulations in
part 56 of this chapter, informed
consent regulations in part 50 of this
chapter, or GCP described in 812.28(a)
of this chapter, was not conducted in
compliance with those regulations such
PO 00000
Frm 00037
Fmt 4702
Sfmt 4702
that the rights or safety of human
subjects were not adequately protected
or the supporting data were determined
to be otherwise unreliable;
(10) A clinical or nonclinical study
necessary to demonstrate that general
controls or general and special controls
provide reasonable assurance of safety
and effectiveness:
(i) Has not been completed per the
study protocol, or
(ii) Deficiencies related to the
investigation and identified in any
request for additional information under
§ 860.256(b)(1) have not been
adequately addressed; or
(11) After a De Novo request is
accepted for review under § 860.245(b),
the requester makes significant
unsolicited changes to the device’s:
(i) Indications for use; or
(ii) Technological characteristics.
(c) An order declining a De Novo
request will inform the requester of the
deficiencies in the De Novo request,
including each applicable ground for
declining the De Novo request.
(d) FDA will use the criteria specified
in § 860.7 to determine the safety and
effectiveness of a device in deciding
whether to grant or decline a De Novo
request. FDA may use information other
than that submitted by the requester in
making such determination.
■ 6. In part 860, remove all references to
‘‘the act’’ and add in their place ‘‘the
Federal Food, Drug, and Cosmetic Act’’.
Dated: November 27, 2018.
Scott Gottlieb,
Commissioner of Food and Drugs.
[FR Doc. 2018–26378 Filed 12–4–18; 8:45 am]
BILLING CODE 4164–01–P
ENVIRONMENTAL PROTECTION
AGENCY
40 CFR Part 300
[EPA–HQ–SFUND–1987–0002; FRL–9987–
15–Region 5]
National Oil and Hazardous
Substances Pollution Contingency
Plan; National Priorities List: Deletion
of the Tomah Armory Landfill
Superfund Site
Environmental Protection
Agency (EPA).
ACTION: Proposed rule; notification of
intent.
AGENCY:
The Environmental Protection
Agency (EPA) Region 5 is issuing a
Notice of Intent to Delete the Tomah
Armory Landfill Superfund Site (Tomah
Armory Site), located in Tomah,
Wisconsin, from the National Priorities
SUMMARY:
E:\FR\FM\07DEP1.SGM
07DEP1
Federal Register / Vol. 83, No. 235 / Friday, December 7, 2018 / Proposed Rules
List (NPL) and requests public
comments on this proposed action. The
NPL, promulgated pursuant to Section
105 of the Comprehensive
Environmental Response,
Compensation, and Liability Act
(CERCLA) of 1980, as amended, is an
appendix of the National Oil and
Hazardous Substances Pollution
Contingency Plan (NCP). EPA and the
State of Wisconsin, through the
Wisconsin Department of Natural
Resources (WDNR), have determined
that all appropriate response actions
under CERCLA, other than operation
and maintenance, monitoring and fiveyear reviews, have been completed.
However, this deletion does not
preclude future actions under
Superfund.
Comments must be received by
January 7, 2019.
ADDRESSES: Submit your comments,
identified by Docket ID no. EPA–HQ–
SFUND–1987–0002, by mail to
Randolph Cano, NPL Deletion
Coordinator, U.S. Environmental
Protection Agency Region 5 (SR–6J), 77
West Jackson Boulevard, Chicago, IL
60604. Comments may also be
submitted electronically or through
amozie on DSK3GDR082PROD with PROPOSALS1
DATES:
VerDate Sep<11>2014
16:06 Dec 06, 2018
Jkt 247001
hand delivery/courier by following the
detailed instructions in the ADDRESSES
section of the direct final rule located in
the ‘‘Rules and Regulations’’ section of
this Federal Register.
FOR FURTHER INFORMATION CONTACT:
Randolph Cano, NPL Deletion
Coordinator, U.S. Environmental
Protection Agency Region 5 (SR–6J), 77
West Jackson Boulevard, Chicago, IL
60604, (312) 886–6036, email:
cano.randolph@epa.gov.
SUPPLEMENTARY INFORMATION: In the
‘‘Rules and Regulations’’ section of
today’s Federal Register, we are
publishing a direct final Notice of
Deletion of the Tomah Armory
Superfund Site without prior Notice of
Intent to Delete because EPA views this
as a noncontroversial revision and
anticipates no adverse comment. We
have explained our reasons for this
deletion in the preamble to the direct
final Notice of Deletion, and those
reasons are incorporated herein. If we
receive no adverse comment(s) on this
deletion action, we will not take further
action on this Notice of Intent to Delete.
If we receive adverse comment(s), we
will withdraw the direct final Notice of
Deletion, and it will not take effect. We
PO 00000
Frm 00038
Fmt 4702
Sfmt 9990
63147
will, as appropriate, address all public
comments in a subsequent final Notice
of Deletion based on this Notice of
Intent to Delete. We will not institute a
second comment period on this Notice
of Intent to Delete. Any parties
interested in commenting must do so at
this time.
For additional information, see the
direct final Notice of Deletion which is
located in the ‘‘Rules and Regulations’’
section of this Federal Register.
List of Subjects in 40 CFR Part 300
Environmental protection, Air
pollution control, Chemicals, Hazardous
waste, Hazardous substances,
Intergovernmental relations, Penalties,
Reporting and recordkeeping
requirements, Superfund, Water
pollution control, Water supply.
Authority: 33 U.S.C. 1321(d); 42 U.S.C.
9601–9657; E.O. 13626, 77 FR 56749, 3 CFR,
2013 Comp., p. 306; E.O. 12777, 56 FR 54757,
3 CFR, 1991 Comp., p. 351; E.O. 12580, 52
FR 2923, 3 CFR, 1987 Comp., p. 193.
Dated: October 30, 2018.
Cathy Stepp,
Regional Administrator, Region 5.
[FR Doc. 2018–26492 Filed 12–6–18; 8:45 am]
BILLING CODE 6560–50–P
E:\FR\FM\07DEP1.SGM
07DEP1
Agencies
[Federal Register Volume 83, Number 235 (Friday, December 7, 2018)]
[Proposed Rules]
[Pages 63146-63147]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-26492]
=======================================================================
-----------------------------------------------------------------------
ENVIRONMENTAL PROTECTION AGENCY
40 CFR Part 300
[EPA-HQ-SFUND-1987-0002; FRL-9987-15-Region 5]
National Oil and Hazardous Substances Pollution Contingency Plan;
National Priorities List: Deletion of the Tomah Armory Landfill
Superfund Site
AGENCY: Environmental Protection Agency (EPA).
ACTION: Proposed rule; notification of intent.
-----------------------------------------------------------------------
SUMMARY: The Environmental Protection Agency (EPA) Region 5 is issuing
a Notice of Intent to Delete the Tomah Armory Landfill Superfund Site
(Tomah Armory Site), located in Tomah, Wisconsin, from the National
Priorities
[[Page 63147]]
List (NPL) and requests public comments on this proposed action. The
NPL, promulgated pursuant to Section 105 of the Comprehensive
Environmental Response, Compensation, and Liability Act (CERCLA) of
1980, as amended, is an appendix of the National Oil and Hazardous
Substances Pollution Contingency Plan (NCP). EPA and the State of
Wisconsin, through the Wisconsin Department of Natural Resources
(WDNR), have determined that all appropriate response actions under
CERCLA, other than operation and maintenance, monitoring and five-year
reviews, have been completed. However, this deletion does not preclude
future actions under Superfund.
DATES: Comments must be received by January 7, 2019.
ADDRESSES: Submit your comments, identified by Docket ID no. EPA-HQ-
SFUND-1987-0002, by mail to Randolph Cano, NPL Deletion Coordinator,
U.S. Environmental Protection Agency Region 5 (SR-6J), 77 West Jackson
Boulevard, Chicago, IL 60604. Comments may also be submitted
electronically or through hand delivery/courier by following the
detailed instructions in the ADDRESSES section of the direct final rule
located in the ``Rules and Regulations'' section of this Federal
Register.
FOR FURTHER INFORMATION CONTACT: Randolph Cano, NPL Deletion
Coordinator, U.S. Environmental Protection Agency Region 5 (SR-6J), 77
West Jackson Boulevard, Chicago, IL 60604, (312) 886-6036, email:
[email protected].
SUPPLEMENTARY INFORMATION: In the ``Rules and Regulations'' section of
today's Federal Register, we are publishing a direct final Notice of
Deletion of the Tomah Armory Superfund Site without prior Notice of
Intent to Delete because EPA views this as a noncontroversial revision
and anticipates no adverse comment. We have explained our reasons for
this deletion in the preamble to the direct final Notice of Deletion,
and those reasons are incorporated herein. If we receive no adverse
comment(s) on this deletion action, we will not take further action on
this Notice of Intent to Delete. If we receive adverse comment(s), we
will withdraw the direct final Notice of Deletion, and it will not take
effect. We will, as appropriate, address all public comments in a
subsequent final Notice of Deletion based on this Notice of Intent to
Delete. We will not institute a second comment period on this Notice of
Intent to Delete. Any parties interested in commenting must do so at
this time.
For additional information, see the direct final Notice of Deletion
which is located in the ``Rules and Regulations'' section of this
Federal Register.
List of Subjects in 40 CFR Part 300
Environmental protection, Air pollution control, Chemicals,
Hazardous waste, Hazardous substances, Intergovernmental relations,
Penalties, Reporting and recordkeeping requirements, Superfund, Water
pollution control, Water supply.
Authority: 33 U.S.C. 1321(d); 42 U.S.C. 9601-9657; E.O. 13626,
77 FR 56749, 3 CFR, 2013 Comp., p. 306; E.O. 12777, 56 FR 54757, 3
CFR, 1991 Comp., p. 351; E.O. 12580, 52 FR 2923, 3 CFR, 1987 Comp.,
p. 193.
Dated: October 30, 2018.
Cathy Stepp,
Regional Administrator, Region 5.
[FR Doc. 2018-26492 Filed 12-6-18; 8:45 am]
BILLING CODE 6560-50-P